Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
International Journal of Molecular Sciences|August 7, 2021
Cells to the Rescue: Emerging Cell-Based Treatment Approaches for NMOSD and MOGADJudith Derdelinckx, Tatjana Reynders, Inez Wens, et al.
Eneurologicalsci|December 21, 2017
Definition, prevalence and predictive factors of benign multiple sclerosisTatjana Reynders, Miguel D'haeseleer, Jacques De Keyser, et al.
Journal of Neurology|September 7, 2018
Targeting phosphocreatine metabolism in relapsing-remitting multiple sclerosis: evaluation with brain MRI, <sup>1</sup>H and <sup>31</sup>P MRS, and clinical and cognitive testingMelissa Cambron, Tatjana Reynders, Jan Debruyne, et al.
Journal of Clinical Medicine|December 28, 2019
Stronger Correlations between Neurophysiological and Peripheral Disease Biomarkers Predict Better Prognosis in Two Severe DiseasesYori Gidron, Marijke De Couck, Tatjana Reynders, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|October 19, 2021
Neuromyelitis Optica Spectrum Disorders in Africa: A Systematic ReviewAbdu Kisekka Musubire, Judith Derdelinckx, Tatjana Reynders, et al.
Multiple Sclerosis and Related Disorders|July 9, 2022
Lifestyle factors in multiple sclerosis disability progression and silent brain damage: A cross-sectional studyLiesbeth Van Hijfte, Griet Loret, Helen Bachmann, et al.
Annals of Clinical and Translational Neurology|March 13, 2020
Gut microbiome variation is associated to Multiple Sclerosis phenotypic subtypesTatjana Reynders, Lindsay Devolder, Mireia Valles-Colomer, et al.
Cells|December 22, 2020
HLA Class II Genotype Does Not Affect the Myelin Responsiveness of Multiple Sclerosis PatientsJudith Derdelinckx, Irene Nkansah, Naomi Ooms, et al.
Journal of Clinical Medicine|December 22, 2019
Relation between Heart Rate Variability and Disease Course in Multiple SclerosisTatjana Reynders, Yori Gidron, Jella De Ville, et al.
European Journal of Neurology|November 11, 2025
Recent Advances in Interventions Targeting Remyelination and a Systematic Review of Remyelinating Effects of Approved Disease-Modifying Treatments for Multiple SclerosisAnna-Victoria De Keersmaecker, Eline van Doninck, Inez Wens, et al.
Pageof 2